Search Pages
PrintPrint EmailEmail
Jaydeep M Bhatt

Biosketch / Results /

Jaydeep M Bhatt, M.D.

Clinical Assistant Professor;
Department of Neurology (Neurology)

Clinical Addresses

650 FIRST AVENUE, 4TH FLOOR
NEW YORK, NY 10016
Hours: Mon. 10 - 5; Tue. 10 - 5; Wed. 10 - 5; Thu. 10 - 5; Fri. 10 - 5
Handicap Access: yes
Phone: 212-696-2726
Fax: 212-685-4162

« Back to Results

Medical Specialties

Neurology

Medical Expertise

Back/Spine Problems, Headaches (Migraines), Neuropathy, Nerve And Muscle Diseases, Myasthenia Gravis, Seizure Disorders (Epilepsy), General Neurology, Emg/Eeg/Evoked Potential, Neurophysiology, Weakness, Gait Disturbances, Dizziness/Vertigo, Stroke

Clinical Responsibilities

Dr. Bhatt is board certified in Neurology and Electrodiagnostic Medicine (EMG). He is an active Neurology attending at NYU Langone Medical Center and also evaluates office patients with neurological disorders.

Languages

Gujurati, Spanish

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO, Beech St PPO, Cigna HMO/POS, Cigna PPO, EBCBS CHLD HLTH, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, GREATWEST PPO, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MULTIPLAN/PHCS PPO, NYS EMPIRE PLAN, OXFORD FREEDOM, UHC EPO, UHC HMO, UHC POS, UHC PPO, UHC TOP TIER, UPN Elite

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2008 — Neurology

Education

1998-2002 — New York University School of Medicine, Medical Education
2002-2003 — SUNY at Stony Brook (Internal Medicine), Internship
2003-2006 — Beth Israel Deaconess Medical Center (Neurology), Residency Training
2006-2008 — Columbia University College of Physicians & Surgeons (Neuromuscular Diseas), Clinical Fellowships

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search#about

Singultus as a sequelae of lateral medullary infarction: Rehabilitation perspective. A case report
Kim, Eric; Bhatt, Jaydep
2011 ;15(1):25-27, Rehabilitacja medyczna = Medical rehabilitation
Hiccups are a rare manifestation of Lateral Medullary Infarction (LMI). Strokes produce numerous complications, hiccup manifestations are limited in reviewing literatures. Diagnoses of LMIs have been documented predominately by use of MRIs. There have been attempts to make clinical with MRI correlations in patients with LMI, studies with a large number of patients are uncommon among subjects with this etiology. Previous literatures have attempted to investigate anatomical lesions in patients with LMI suffering from hiccups by using imaging. Initial signs are usually headache, vertigo, dizziness or gait ataxia, whereas sensory symptoms consisting of dysphagia, hoarseness and hiccups usually occurred in the latter aspect. Hiccups in LMI are not fully understood and has been insufficiently studied. We describe a case of a man in his sixties with a constant occipital headache lasting 12 days associated with nausea and vomiting prior to admission to acute hospital. There was no history of exposure to any prescription or recreational drugs prior to presentation. The day after admission, he presented with intractable hiccups. Treatment with chlorpromazine (Thorazine) was unsuccessful, hiccups improved after initiation of baclofen and physical therapy. This case suggests that physical therapy may be a valuable aspect for refractory hiccups in conjunction with pharmacological management
— id: 140415, year: 2011, vol: 15, page: 25, stat: Journal Article,

Amyotrophic lateral sclerosis (ALS)
Bhatt JM; Mitsumoto H
Encyclopedia of neuroscience Berlin: Elsevier, 2009,
— id: 4995, year: 2009, vol: , page: 363, stat: Chapter,

Current clinical trials in amyotrophic lateral sclerosis
Bhatt, Jaydeep M; Gordon, Paul H
2007 Aug;16(8):1197-1207, Expert opinion on investigational drugs
Amyotrophic lateral sclerosis is caused by selective degeneration of motor neurons in the brain and spinal cord. There are still no other effective therapies 10 years after the approval of riluzole for the treatment of amyotrophic lateral sclerosis, but advances in drug development and screening are substantially increasing the number of potential therapeutic agents. This review provides an overview of clinical trial methodology in amyotrophic lateral sclerosis followed by a systematic evaluation of drugs that are presently in Phase I, II and III clinical trials. There is an emphasis on the scientific evidence supporting the selection of each drug being tested, as well as on trial design
— id: 78406, year: 2007, vol: 16, page: 1197, stat: Journal Article,